Nanjing King-Friend Biochemical Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nanjing King-Friend Biochemical Pharmaceutical Co Ltd with three other
companies in this sector in China:
Pulike Biological Engineering Inc
sales of 583.09 million Chinese Renmimbi [US$90.62 million]
of which 93%
was Veterinary Chemicals),
Zhenxing Biopharmaceutical & Chemical Co Ltd
(567.44 million Chinese Renmimbi [US$88.19 million]
of which 100%
was Pharmaceutical Sales), and
Walvax Biotechnology Company Limited
(590.16 million Chinese Renmimbi [US$91.72 million]
of which 38%
was Autonomous Vaccine).